Injection preparation and method for producing same
Provided are an injection preparation which include: an aqueous composition containing pemetrexed or a salt thereof, at least one antioxidant agent which is selected from the group consisting of ascorbic acid, an ascorbic acid derivative, and salts thereof, and the content of which is 0.0001 mass % to 0.5 mass % with respect to the total mass of the aqueous composition in terms of ascorbic acid, and an aqueous solvent of greater than or equal to 50 mass % with respect to the total mass of the aqueous composition; and a container which encloses the aqueous composition, in which the concentration of oxygen in gas within the container which encloses the aqueous composition is less than or equal to 0.2 volume %, and a method for producing the injection preparation.
1. An injection preparation comprising:
an aqueous composition containing the following (i) to (iv); and
a container which encloses the aqueous composition,
wherein the concentration of oxygen in gas within the container which encloses the aqueous composition is less than or equal to 1.5 volume %:
(i) pemetrexed or a salt thereof;
(ii) at least one antioxidant agent A which is at least one selected from the group consisting of ascorbic acid, trisodium ascorbyl phosphate, and sodium ascorbate, and the content of which is 0.001 mass % to 1.0 mass % with respect to the total mass of the aqueous composition in terms of ascorbic acid;
(iii) at least one antioxidant agent B which is at least one selected from the group consisting of cysteine, a salt thereof, and thioglycerol, and the content of which is 0.00050 mass % to 0.15 mass % with respect to the total mass of the aqueous composition; and
(iv) an aqueous solvent of greater than or equal to 50 mass % with respect to the total mass of the aqueous composition.
2. An injection preparation comprising:
an aqueous composition; and
a container which encloses the aqueous composition,
wherein the aqueous composition contains the following (i) to (iv), and
wherein the ratio of the number of oxygen molecules with respect to the number of pemetrexed molecules in the injection preparation is less than or equal to 0.0120:
(i) pemetrexed or a salt thereof;
(ii) at least one antioxidant agent A which is at least one selected from the group consisting of ascorbic acid, trisodium ascorbyl phosphate, and sodium ascorbate, and the content of which is 0.001 mass % to 1.0 mass % with respect to the total mass of the aqueous composition in terms of ascorbic acid;
(iii) at least one antioxidant agent B which is at least one selected from the group consisting of cysteine, a salt thereof, and thioglycerol, and the content of which is 0.00050 mass % to 0.15 mass % with respect to the total mass of the aqueous composition; and
(iv) an aqueous solvent of greater than or equal to 50 mass % with respect to the total mass of the aqueous composition.
3. The injection preparation according to claim 1 ,
wherein the at least one antioxidant agent B includes cysteine or a salt thereof.
4. The injection preparation according to claim 1 ,
wherein the at least one antioxidant agent B includes cysteine or a salt thereof, and thioglycerol.
5. The injection preparation according to claim 1 ,
wherein the content of the antioxidant agent A is 0.005 mass % to 0.5 mass % with respect to the total mass of the aqueous composition.
6. The injection preparation according to claim 1 ,
wherein the content of the antioxidant agent B is 0.0050 mass % to 0.15 mass % with respect to the total mass of the aqueous composition.
7. The injection preparation according to claim 1 ,
wherein the ratio of the content of the antioxidant agent A to the content of the antioxidant agent B is 1:0.05 to 1:10 on a mass basis.
8. The injection preparation according to claim 1 ,
wherein the pH of the aqueous composition is higher than 5.5 and less than or equal to 9.5.
9. The injection preparation according to claim 1 ,
wherein the aqueous composition contains at least one pH modifier selected from the group consisting of hydrochloric acid, sodium hydroxide, phosphoric acid or a salt thereof, citric acid or a salt thereof, triethanolamine, trometamol, and disodium edetate.
10. The injection preparation according to claim 9 ,
wherein the pH modifier is at least one selected from citric acid or a salt thereof.
11. A method for producing an injection preparation, comprising:
producing an aqueous composition which contains:
(i) pemetrexed or a salt thereof,
(ii) at least one antioxidant agent A which is at least one selected from the group consisting of ascorbic acid, trisodium ascorbyl phosphate, and sodium ascorbate, and the content of which is 0.001 mass % to 1.0 mass % with respect to the total mass of the aqueous composition in terms of ascorbic acid;
(iii) at least one antioxidant agent B which is at least one selected from the group consisting of cysteine, a salt thereof, and thioglycerol, and the content of which is 0.00050 mass % to 0.15 mass % with respect to the total mass of the aqueous composition; and
(iv) an aqueous solvent of greater than or equal to 50 mass % with respect to the total mass of the aqueous composition; and
filling a container with the aqueous composition under an inert gas atmosphere or substituting gas within the container with inert gas after filling the container with the aqueous composition.
12. The production method according to claim 11 ,
wherein the inert gas is nitrogen.